ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
艾格里房產
71.23
-0.2600
-0.36%
盤後：
71.23
0.0000
0.00%
19:52 EDT
成交量：
141.24萬
成交額：
1.01億
市值：
88.60億
市盈率：
38.47
高：
71.87
開：
71.87
低：
70.97
收：
71.49
52周最高：
82.08
52周最低：
69.56
股本：
1.24億
流通股本：
1.22億
量比：
1.02
換手率：
1.16%
股息：
3.14
股息率：
4.41%
每股收益(TTM):
1.85
每股收益(LYR):
1.77
淨資產收益率：
3.70%
總資產收益率：
2.40%
市淨率：
1.40
市盈率(LYR):
40.24
資料載入中...
總覽
公司
新聞
公告
諾誠健華盤中升逾9% 自研靶向CDH17的新型ADC創新藥ICP-B208完成首例患者給藥
新浪港股
·
07/06
博騰雙載荷ADC IND成功交付
智通财经
·
07/03
芯海科技：性能參數方面，功耗、安全、軟件生態、ADC精度、主頻均處於行業領先水平
证券日报网
·
07/02
雙抗ADC新藥宜澤康®在蓉首發
智通财经
·
06/30
557個藥品通過2026年醫保目錄初審，總體通過率92%
新京报
·
06/30
【券商聚焦】國金證券：創新藥企業扭虧節點已至 持續關注小核酸、雙抗、ADC
金吾财讯
·
06/30
「纏腰龍」劇痛無解？全球首款mRNA帶狀皰疹疫苗開啓萬人臨床；全球首個雙抗ADC將展開HR+/HER2-乳腺癌III期臨床研究 | 掘金創新藥
每日经济新闻
·
06/24
【灣區早參】香港5月基本綜合消費物價指數按年上升1.9%；深圳發布《中小企業品牌出海實施指南》團體標準
金吾财讯
·
06/24
「魔法子彈」升級，全球首個國產雙抗ADC新藥獲批，晚期鼻咽癌患者迎新選擇
上观新闻
·
06/23
中國生物製藥(01177)：維特柯妥拜單抗「CLDN18.2 ADC」新藥上市申請獲得受理
智通财经
·
06/23
國產創新藥三箭齊發：全球首個雙抗ADC、全球首個治療實體瘤的CAR-T產品、全球首個狂犬病雙抗同日獲批
每日经济新闻
·
06/22
全球首個獲批雙抗ADC上市，百利天恒(688506.SH)加速向MNC跨代躍遷
智通财经
·
06/22
港股ADC龍頭映恩生物衝刺科創板：現金流與在研產品面臨大考，創新藥企「回A」趨勢隱現
蓝鲸财经
·
06/15
新諾威(300765.SZ)：SYS6041(葉酸受體ADC)獲得藥物臨床試驗批准
智通财经
·
06/15
百利天恒：EGFR×HER3雙抗ADC藥品上市申請獲受理
财中社
·
06/14
百利天恒：注射用BL-M14D1（DLL3 ADC）獲臨床試驗批准
南方财经网
·
06/14
映恩生物(09606)上交所科創板IPO已受理 深耕於抗體偶聯藥物(ADC)領域
智通财经
·
06/12
港股異動 | 君實生物(01877)升逾5% 近日擬入股上海致域生物醫藥 佈局ADC與多特異抗體研發
智通财经
·
06/12
【灣區早參】港珠澳大橋香港口岸本月25日將啓用「無感通關」；深圳上榜畢業旅行十大熱門城市
金吾财讯
·
06/12
基石藥業-B(02616)：CS5007(EGFR/HER3雙特異性ADC)全球多中心I期臨床試驗啓動
智通财经
·
06/12
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/ADC/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房產","latestPrice":71.23,"timestamp":1789156800000,"preClose":71.49,"halted":0,"volume":1412407,"hourTrading":{"tag":"盘后","latestPrice":71.23,"preClose":71.23,"latestTime":"19:52 EDT","volume":89152,"amount":6350271.741,"timestamp":1789170728005,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0036368722898306185,"floatShares":122178283,"shares":124379300,"eps":1.85165,"marketStatus":"休市中","change":-0.26,"latestTime":"09-11 16:00:00 EDT","open":71.87,"high":71.87,"low":70.97,"amount":100637967.61366999,"amplitude":0.012589,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.85165,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":71.49,"dividendRate":0.044097,"preHourTrading":{"tag":"盘前","latestPrice":71.505,"preClose":71.49,"latestTime":"08:41 EDT","volume":181,"amount":13184.721465,"timestamp":1789130514795,"change":0.015,"changeRate":0.00021,"amplitude":0.038607},"postHourTrading":{"tag":"盘后","latestPrice":71.23,"preClose":71.23,"latestTime":"19:52 EDT","volume":89152,"amount":6350271.741,"timestamp":1789170728005,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0182799229051516,"impliedVol":0.2095,"impliedVolPercentile":0.259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":122178283,"roa":"2.40%","roe":"3.70%","lyrEps":1.77,"volumeRatio":1.0182799229051516,"shares":124379300,"dividePrice":3.141,"high":71.87,"amplitude":0.012589,"preClose":71.49,"low":70.97,"week52Low":69.56,"pbRate":"1.40","psRate":"11.36","week52High":82.08,"institutionHeld":0.85,"latestPrice":71.23,"eps":1.85165,"divideRate":0.044097,"volume":1412407,"delay":0,"ttmEps":1.85165,"open":71.87,"prevYearClose":72.03,"prevWeekClose":72.62,"prevMonthClose":72.25,"prevQuarterClose":75.74,"fiveDayClose":72.73,"twentyDayClose":75.11,"sixtyDayClose":74.73,"dividendPayoutRate":1.7363850728368737,"dividendFrequency":"M","dividendGrowthYears":10,"dividendGrowthRate":0.026999999999999986,"fiveYearAvgDividendRate":0.041531731300358074},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2026-09-30","symbol":"ADC","amount":0.267,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-30","defaultRemindTime":1790775000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-14","payableDate":"2026-09-30","currency":"USD","dateTimestamp":1790740800000,"payDate":"2026-10-14"},{"date":"2026-08-31","symbol":"ADC","amount":0.267,"announcedDate":"2026-08-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-31","defaultRemindTime":1788183000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-15","payableDate":"2026-08-31","currency":"USD","dateTimestamp":1788148800000,"payDate":"2026-09-15"},{"date":"2026-07-31","symbol":"ADC","amount":0.267,"announcedDate":"2026-07-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-31","defaultRemindTime":1785504600000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-14","payableDate":"2026-07-31","currency":"USD","dateTimestamp":1785470400000,"payDate":"2026-08-14"},{"date":"2026-07-30","symbol":"ADC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":1.11,"defaultRemindTime":1785441600000,"name":null,"time":"盤後","dateTimestamp":1785384000000,"actualEps":null},{"date":"2026-06-30","symbol":"ADC","amount":0.267,"announcedDate":"2026-06-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-30","defaultRemindTime":1782826200000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-15","payableDate":"2026-06-30","currency":"USD","dateTimestamp":1782792000000,"payDate":"2026-07-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-28","recordDate":"2016-09-30","paymentDate":"2016-10-14","value":0.48,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2017-01-03","value":0.495,"currency":"USD"},{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-14","value":0.495,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-14","value":0.505,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-13","value":0.505,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2381,"buy":0.381,"hold":0.381,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.381,"analysts":21,"updateTime":1784088000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2026-09-11","current":38.468393,"percent":0.333605,"low":31.539495,"twenty":37.632574,"median":41.2516,"eighty":43.588862,"high":50.705944,"avg":40.750955,"sd":3.756081,"marketCap":8878508241},"quantilePoints":[{"date":"2021-09-17","current":50.119952,"twenty":31.977009,"median":39.430911,"eighty":44.835833,"marketCap":4879377818},{"date":"2021-09-24","current":47.775985,"twenty":31.977009,"median":39.430911,"eighty":44.888065,"marketCap":4651183223},{"date":"2021-10-01","current":47.352376,"twenty":31.977009,"median":39.430911,"eighty":44.941549,"marketCap":4609943235},{"date":"2021-10-08","current":47.670083,"twenty":31.977009,"median":39.430911,"eighty":44.9864,"marketCap":4640873226},{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066},{"date":"2025-04-25","current":43.782817,"twenty":37.571542,"median":40.572736,"eighty":44.653759,"marketCap":8377141546},{"date":"2025-05-02","current":45.953462,"twenty":37.571542,"median":40.583839,"eighty":44.677947,"marketCap":8792459672},{"date":"2025-05-09","current":43.031008,"twenty":37.571542,"median":40.598117,"eighty":44.677947,"marketCap":8233294969},{"date":"2025-05-16","current":42.422675,"twenty":37.571542,"median":40.624906,"eighty":44.677947,"marketCap":8116900028},{"date":"2025-05-23","current":42.755537,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8180587826},{"date":"2025-05-30","current":42.698147,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8169607171},{"date":"2025-06-06","current":42.411197,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8114703897},{"date":"2025-06-13","current":42.927706,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8213529790},{"date":"2025-06-20","current":43.220395,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8269531129},{"date":"2025-06-27","current":41.894687,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8015878004},{"date":"2025-07-03","current":41.30357,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7902777259},{"date":"2025-07-11","current":40.735409,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7794068777},{"date":"2025-07-18","current":41.234702,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7889600473},{"date":"2025-07-25","current":42.319373,"twenty":37.604201,"median":40.725789,"eighty":44.606841,"marketCap":8097134849},{"date":"2025-08-01","current":42.372392,"twenty":37.604201,"median":40.742491,"eighty":44.606841,"marketCap":7873129491},{"date":"2025-08-08","current":43.918584,"twenty":37.604201,"median":40.752858,"eighty":44.633348,"marketCap":8160424292},{"date":"2025-08-15","current":42.901923,"twenty":37.604201,"median":40.790693,"eighty":44.633348,"marketCap":7971520467},{"date":"2025-08-22","current":44.019656,"twenty":37.604201,"median":40.820493,"eighty":44.633348,"marketCap":8179204204},{"date":"2025-08-29","current":43.199192,"twenty":37.604201,"median":40.894276,"eighty":44.633348,"marketCap":8026755504},{"date":"2025-09-05","current":42.806797,"twenty":37.595885,"median":40.935905,"eighty":44.639951,"marketCap":7953845256},{"date":"2025-09-12","current":43.841294,"twenty":37.604201,"median":40.969944,"eighty":44.633348,"marketCap":8146063183},{"date":"2025-09-19","current":42.527363,"twenty":37.604201,"median":41.008406,"eighty":44.633348,"marketCap":7901924321},{"date":"2025-09-26","current":41.962551,"twenty":37.639342,"median":41.035693,"eighty":44.633348,"marketCap":7796977752},{"date":"2025-10-03","current":42.027951,"twenty":37.639342,"median":41.102705,"eighty":44.633348,"marketCap":7809129460},{"date":"2025-10-10","current":41.974442,"twenty":37.639342,"median":41.115788,"eighty":44.633348,"marketCap":7799187153},{"date":"2025-10-17","current":44.322871,"twenty":37.639342,"median":41.17126,"eighty":44.633348,"marketCap":8235543942},{"date":"2025-10-24","current":44.544295,"twenty":37.639342,"median":41.220151,"eighty":44.656944,"marketCap":8621592904},{"date":"2025-10-31","current":43.1986,"twenty":37.639342,"median":41.2516,"eighty":44.656944,"marketCap":8361132219},{"date":"2025-11-07","current":42.991114,"twenty":37.639342,"median":41.30357,"eighty":44.656944,"marketCap":8320973082},{"date":"2025-11-14","current":43.690638,"twenty":37.639342,"median":41.35326,"eighty":44.656944,"marketCap":8456366743},{"date":"2025-11-21","current":43.68471,"twenty":37.639342,"median":41.452784,"eighty":44.656944,"marketCap":8455219339},{"date":"2025-11-28","current":44.591721,"twenty":37.639342,"median":41.521652,"eighty":44.656944,"marketCap":8630772135},{"date":"2025-12-05","current":44.093754,"twenty":37.639342,"median":41.583569,"eighty":44.656944,"marketCap":8534390208},{"date":"2025-12-12","current":42.244164,"twenty":37.639342,"median":41.619337,"eighty":44.656944,"marketCap":8176400191},{"date":"2025-12-19","current":42.902191,"twenty":37.639342,"median":41.692355,"eighty":44.656944,"marketCap":8303762024},{"date":"2025-12-26","current":42.919976,"twenty":37.639342,"median":41.746748,"eighty":44.656944,"marketCap":8307204236},{"date":"2026-01-02","current":42.700633,"twenty":37.639342,"median":41.754028,"eighty":44.656944,"marketCap":8264750291},{"date":"2026-01-09","current":41.977396,"twenty":37.639342,"median":41.778924,"eighty":44.654358,"marketCap":8124767015},{"date":"2026-01-16","current":42.688777,"twenty":37.639342,"median":41.778924,"eighty":44.603089,"marketCap":8262455483},{"date":"2026-01-23","current":42.700633,"twenty":37.639342,"median":41.778924,"eighty":44.565186,"marketCap":8264750291},{"date":"2026-01-30","current":42.659136,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":8256718464},{"date":"2026-02-06","current":45.131184,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":8735185890},{"date":"2026-02-13","current":44.908403,"twenty":37.639342,"median":41.778924,"eighty":44.506847,"marketCap":9176987197},{"date":"2026-02-20","current":45.230936,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":9242896611},{"date":"2026-02-27","current":46.784962,"twenty":37.639342,"median":41.778924,"eighty":44.52786,"marketCap":9560460154},{"date":"2026-03-06","current":47.517993,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9710254277},{"date":"2026-03-13","current":46.714591,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9546079918},{"date":"2026-03-20","current":46.13403,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9427442972},{"date":"2026-03-27","current":43.629997,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":8915746245},{"date":"2026-04-02","current":44.474448,"twenty":37.639342,"median":41.778924,"eighty":44.463484,"marketCap":9088309076},{"date":"2026-04-10","current":45.752298,"twenty":37.639342,"median":41.778924,"eighty":44.447073,"marketCap":9349436265},{"date":"2026-04-17","current":46.315619,"twenty":37.639342,"median":41.778924,"eighty":44.447073,"marketCap":9464550524},{"date":"2026-04-24","current":42.221567,"twenty":37.639342,"median":41.778924,"eighty":44.388105,"marketCap":9263580602},{"date":"2026-05-01","current":42.145034,"twenty":37.639342,"median":41.773945,"eighty":44.310918,"marketCap":9246788997},{"date":"2026-05-08","current":41.718719,"twenty":37.639342,"median":41.749425,"eighty":44.205061,"marketCap":9153253847},{"date":"2026-05-15","current":41.144834,"twenty":37.639342,"median":41.735116,"eighty":44.170042,"marketCap":9027341145},{"date":"2026-05-22","current":41.363457,"twenty":37.639342,"median":41.708673,"eighty":44.159332,"marketCap":9075307889},{"date":"2026-05-29","current":40.745847,"twenty":37.635958,"median":41.645687,"eighty":44.142784,"marketCap":8939801838},{"date":"2026-06-05","current":39.477834,"twenty":37.639342,"median":41.613421,"eighty":44.076208,"marketCap":8661594725},{"date":"2026-06-12","current":40.871555,"twenty":37.639342,"median":41.561825,"eighty":44.020119,"marketCap":8967382716},{"date":"2026-06-18","current":40.341395,"twenty":37.639342,"median":41.522683,"eighty":43.960147,"marketCap":8851063362},{"date":"2026-06-26","current":41.527424,"twenty":37.635958,"median":41.458055,"eighty":43.866662,"marketCap":9111282946},{"date":"2026-07-02","current":41.691391,"twenty":37.635958,"median":41.455214,"eighty":43.838916,"marketCap":9147258004},{"date":"2026-07-10","current":42.549486,"twenty":37.635958,"median":41.455214,"eighty":43.812381,"marketCap":9335527473},{"date":"2026-07-17","current":44.134502,"twenty":37.635958,"median":41.455214,"eighty":43.800235,"marketCap":9683286364},{"date":"2026-07-24","current":43.620739,"twenty":37.635958,"median":41.455214,"eighty":43.790532,"marketCap":9570564516},{"date":"2026-07-31","current":43.306779,"twenty":37.632574,"median":41.452784,"eighty":43.772108,"marketCap":9737919027},{"date":"2026-08-07","current":42.169016,"twenty":37.632574,"median":41.452784,"eighty":43.730794,"marketCap":9482082868},{"date":"2026-08-14","current":41.48415,"twenty":37.632574,"median":41.412647,"eighty":43.686617,"marketCap":9328084404},{"date":"2026-08-21","current":41.119624,"twenty":37.632574,"median":41.35326,"eighty":43.679447,"marketCap":9246117479},{"date":"2026-08-28","current":40.429234,"twenty":37.632574,"median":41.30357,"eighty":43.643751,"marketCap":9090877092},{"date":"2026-09-04","current":40.169647,"twenty":37.632574,"median":41.279794,"eighty":43.619299,"marketCap":9032506706},{"date":"2026-09-11","current":39.48478,"twenty":37.632574,"median":41.2516,"eighty":43.588862,"marketCap":8878508241}],"updateTime":1789342934014},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649461757","title":"諾誠健華盤中升逾9% 自研靶向CDH17的新型ADC創新藥ICP-B208完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2649461757","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649461757?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 09:52","pubTimestamp":1783302720,"startTime":"0","endTime":"0","summary":" 诺诚健华盘中涨超9%，截至发稿，股价上涨6.42%，现报13.92港元，成交额5426.90万港元。 7月6日，据诺诚健华官微消息，公司宣布自主研发的靶向CDH17的新型ADC创新药ICP-B208完成首例患者给药。基于诺诚健华自主研发的ADC技术平台，ICP-208由人源化抗CDH17抗体通过蛋白酶可裂解连接子与公司自主开发的强效有效载荷偶联而成，可精准靶向肿瘤细胞，同时最大限度减少脱靶效应。目前，全球尚无CDH17靶向ADC新药上市。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-06/doc-inifvqsf1795989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4080","ADC","BK1574","NETL","159992","MEDX","BK1161","09969","IBBQ","688428","06978","BK4231","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648630681","title":"博騰雙載荷ADC IND成功交付","url":"https://stock-news.laohu8.com/highlight/detail?id=2648630681","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648630681?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 11:05","pubTimestamp":1783047950,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4080","BK4231","ADC","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648980686","title":"芯海科技：性能參數方面，功耗、安全、軟件生態、ADC精度、主頻均處於行業領先水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2648980686","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648980686?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 22:01","pubTimestamp":1783000860,"startTime":"0","endTime":"0","summary":"证券日报网7月2日讯，芯海科技在接受调研者提问时表示，性能参数方面，功耗、安全、软件生态、ADC精度、主频均处于行业领先水平。例如，传统EC主频通常为9.6兆，公司产品为百兆主频，除基础功能外可承担管理中枢作用，还具备AI相关能力；公司是全球首个联合联想发布基于Zephyr操作系统EC的厂商；公司推行IPD集成产品开发体系，保障产品高成熟度，是半导体行业为数不多横跨消费、工业、汽车三大领域的企业，产品已通过消费级、工业级、车规级相关品牌客户的认证。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-02/doc-inifmrts2638484.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-02/doc-inifmrts2638484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4080","BK4585","VGT","688595","ADC","BK4588","159180","BK4231","BK0214"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647801385","title":"雙抗ADC新藥宜澤康®在蓉首發","url":"https://stock-news.laohu8.com/highlight/detail?id=2647801385","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647801385?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 14:56","pubTimestamp":1782802595,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ADC","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647002589","title":"557個藥品通過2026年醫保目錄初審，總體通過率92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647002589","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647002589?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 11:17","pubTimestamp":1782789420,"startTime":"0","endTime":"0","summary":"6月29日，国家医保局对通过2026年国家基本医疗保险、生育保险和工伤保险药品目录及商保创新药目录调整初步形式审查的药品进行公示，共有557个药品通过初步形式审查。此外，还有54个申请商保创新药目录通用名通过初审。按照国家医保局公布的进度，今年8-9月将进行测算谈判，11月将公布调整后的新版医保目录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606303788079689.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303788079689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","ADC","06978","BK4231","BK4080","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647358924","title":"【券商聚焦】國金證券：創新藥企業扭虧節點已至 持續關注小核酸、雙抗、ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2647358924","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647358924?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 11:13","pubTimestamp":1782789198,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国金证券研究指，创新药企业扭亏节点到来，全年临床数据催化密集，叠加已BD出海管线海外临床进展顺利，看好创新药板块投资机会。具体布局思路而言：(1)布局业绩财报窗口期，掘金业绩超预期标的；(2)关注学会大会动态，把握重磅临床数据发布窗口；(3)聚焦核心赛道，持续关注小核酸、双抗、ADC等相关标的的投资机会。风险提示：汇兑风险、投融资周期波动风险、并购整合不及预期的风险、数据安全与隐私合规风险等。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984822","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK0183","BK0201","BK0276","06978","BK1574","BK0188","BK0012","159992","BK4080","600109","BK0028","ADC","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645816545","title":"「纏腰龍」劇痛無解？全球首款mRNA帶狀皰疹疫苗開啓萬人臨床；全球首個雙抗ADC將展開HR+/HER2-乳腺癌III期臨床研究 | 掘金創新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2645816545","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645816545?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 21:24","pubTimestamp":1782307495,"startTime":"0","endTime":"0","summary":"资本眼一周行情上周（6月15日至21日），医药生物指数下跌1.48%，跑输上证指数2.94个百分点。创新药（BK1106）周内下跌0.90%；恒生医疗保健业指数（HSCICH）周内下跌1.83%；港股创新药ETF广发（513120）周内下跌1.97%。机构观点中邮证券我们探讨高潜力特异性皮炎（AD）市场的下一个方向：口服+新作用机制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243781663812.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243781663812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK4203","III","159992","BK4080","BK4225","BK1161","BK4231","ADC","BK1574","HR","BK4134","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645687218","title":"【灣區早參】香港5月基本綜合消費物價指數按年上升1.9%；深圳發布《中小企業品牌出海實施指南》團體標準","url":"https://stock-news.laohu8.com/highlight/detail?id=2645687218","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645687218?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 09:11","pubTimestamp":1782263498,"startTime":"0","endTime":"0","summary":"根据综合消费物价指数，2026年5月份整体消费物价与一年前同月比较，上升2.0%，较2026年4月份的相应升幅为高。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984349","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","01364","BK4231","IE00BZ08YT58.USD","BK1555","02460","BK4017","LU1223083913.SGD","BK1616","IE00BZ08YR35.GBP","LU1223082196.USD","BK1200","ADC","LU0211977185.USD","BK1521","BK1191","BK1515","BK1240","IE00BZ08YS42.EUR","HK0000165453.HKD","CDE","00813","LU1223082519.USD","LU2488822045.USD","BK1233","BK4080","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645884463","title":"「魔法子彈」升級，全球首個國產雙抗ADC新藥獲批，晚期鼻咽癌患者迎新選擇","url":"https://stock-news.laohu8.com/highlight/detail?id=2645884463","media":"上观新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645884463?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 17:01","pubTimestamp":1782205265,"startTime":"0","endTime":"0","summary":"晚期鼻咽癌患者迎来新选择，抗癌治疗“魔法子弹”升级了。6月22日，国家药品监督管理局官网消息，我国自主研发的EGFR×HER3双抗ADC药物伦康依隆妥单抗正式获批上市。该药用于治疗既往经至少二线系统化疗和PD-1/PD-L1抑制剂治疗失败的复发/转移性鼻咽癌成人患者，是全球首个获批上市的双抗ADC药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606233779758811.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606233779758811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4080","BK4231","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645815578","title":"中國生物製藥(01177)：維特柯妥拜單抗「CLDN18.2 ADC」新藥上市申請獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2645815578","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645815578?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 16:33","pubTimestamp":1782203634,"startTime":"0","endTime":"0","summary":"本次LM-302上市申请获得受理是基于一项III期关键临床研究的积极成果。除本次申报上市的叁线及以上CLDN18.2阳性局部晚期或转移性GC/GEJ适应症外，LM-302亦在开展联合PD-1单抗用于一线治疗CLDN18.2阳性局部晚期或转移性GC/GEJ的III期关键临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YT58.USD","BK4231","ADC","BK1191","IPOS","BK1521","BK1515","IE00BZ08YS42.EUR","BK1589","HK0000165453.HKD","IE00BZ08YR35.GBP","01177","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645020238","title":"國產創新藥三箭齊發：全球首個雙抗ADC、全球首個治療實體瘤的CAR-T產品、全球首個狂犬病雙抗同日獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2645020238","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645020238?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 21:37","pubTimestamp":1782135422,"startTime":"0","endTime":"0","summary":"2026年6月22日，国家药品监督管理局消息，百利天恒自主研发的EGFR×HER3双抗ADC药物伦康依隆妥单抗、恺兴生命科技（上海）有限公司的舒瑞基奥仑赛注射液、智翔金泰的斯乐韦米单抗在国内获批上市。其中，伦康依隆妥单抗用于治疗既往经至少二线系统化疗和PD-1/PD-L1抑制剂治疗失败的复发/转移性鼻咽癌的成人患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606223778344530.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606223778344530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159992","CAR","BK4230","ADC","06978","BK1161","BK4080","BK1574","BK4231","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645294190","title":"全球首個獲批雙抗ADC上市，百利天恒(688506.SH)加速向MNC跨代躍遷","url":"https://stock-news.laohu8.com/highlight/detail?id=2645294190","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645294190?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 19:01","pubTimestamp":1782126096,"startTime":"0","endTime":"0","summary":"作为全球首创EGFR×HER3双抗ADC，百利天恒的1类新药宜泽康在国内获批上市，用于复发/转移性鼻咽癌后线治疗。6月22日，百利天恒发布的这则重磅公告，引发了市场的广泛关注。本次获批，也标志着肿瘤治疗正式迈入双抗ADC新时代。此次在国内获批上市，是宜泽康加速成为“下一代基石癌症疗法”的第一步。该药由此成为全球第二款迈入III期临床开发的DLL3 ADC药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["91194","688506","BK0239","IPOS","BK4080","02615","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643695272","title":"港股ADC龍頭映恩生物衝刺科創板：現金流與在研產品面臨大考，創新藥企「回A」趨勢隱現","url":"https://stock-news.laohu8.com/highlight/detail?id=2643695272","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643695272?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 18:07","pubTimestamp":1781518028,"startTime":"0","endTime":"0","summary":"日前，港股上市仅一年多的ADC创新药企映恩生物宣布，上交所已正式受理其首次公开发行人民币普通股（A股）并在科创板上市的申请。接下来，映恩将把握机遇，加速核心ADC产品的全球临床与商业化步伐，致力于打造红筹创新药回A标杆。映恩生物能否借科创板融资守住ADC全球第一梯队的研发节奏，并最终兑现管线商业化价值，将是检验这桩“回头路”成色的唯一标尺。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1781516761050238996","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1574","BK4080","BK4585","ADC","159982","159399","BK4588","VXUS","BK4231","159992","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643717712","title":"新諾威(300765.SZ)：SYS6041(葉酸受體ADC)獲得藥物臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2643717712","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643717712?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 17:32","pubTimestamp":1781515927,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新诺威 发布公告，公司的控股子公司石药集团巨石生物制药有限公司于近日收到国家药品监督管理局核准签发关于SYS6041的《药物临床试验批准通知书》，将于近期开展临床试验。SYS6041是一种靶向叶酸受体α(FRα)的抗体-药物偶联物。SYS6041的潜在适应症为妇科肿瘤和肺癌等实体瘤。临床I期试验的现有数据显示，SYS6041在同类产品中具有竞争力。本次获批的SYS6041联合用药临床试验探索研究，将进一步拓展SYS6041的临床应用场景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300765","BK4080","BK4231","BK0226","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643981246","title":"百利天恒：EGFR×HER3雙抗ADC藥品上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2643981246","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643981246?lang=zh_tw&edition=fundamental","pubTime":"2026-06-14 16:05","pubTimestamp":1781424300,"startTime":"0","endTime":"0","summary":"6月14日，百利天恒（688506）发布公告，近日公司收到国家药品监督管理局药品审评中心核准签发的《受理通知书》，公司自主研发的全球首创EGFR×HER3双抗ADC（iza-bren）的药品上市申请已获得正式受理。该药品适用于既往经紫杉烷类治疗失败的不可手术切除的局部晚期或转移性三阴乳腺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606143770689538.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606143770689538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4231","688506","BK0239","IPOS","ADC","02615","91194","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643824657","title":"百利天恒：注射用BL-M14D1（DLL3 ADC）獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2643824657","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643824657?lang=zh_tw&edition=fundamental","pubTime":"2026-06-14 15:48","pubTimestamp":1781423280,"startTime":"0","endTime":"0","summary":"南财智讯6月14日电，百利天恒公告，注射用BL-M14D1（DLL3ADC）收到国家药品监督管理局签发的《药物临床试验批准通知书》（通知书编号：2026LP01761），同意本品开展联合PD-1/PD-L1单抗±抗血管生成药物±化疗治疗广泛期小细胞肺癌的临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606143770687530.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606143770687530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1815336091.USD","BK4080","BL","LU0757428866.USD","91194","BK4023","BK4231","02615","688506","ADC","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642295103","title":"映恩生物(09606)上交所科創板IPO已受理 深耕於抗體偶聯藥物(ADC)領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2642295103","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642295103?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 21:33","pubTimestamp":1781271202,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，6月12日，映恩生物上交所科创板IPO已受理。据招股书，映恩生物是一家深耕于抗体偶联药物领域的全球化创新生物制药企业，致力于成为全球ADC领域的领军者。映恩生物的产品在临床试验中展现了突破性的治疗潜力，目前已累计获得1项 FDA 突破性疗法认定、1项国家药监局突破性疗法认定、5项 FDA 快速通道认定及2项 FDA 孤儿药认定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09606","HK0000500386.USD","ADC","HK0000252160.HKD","IPOS","BK4080","159982","HK0000252152.HKD","BK4231","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642250194","title":"港股異動 | 君實生物(01877)升逾5% 近日擬入股上海致域生物醫藥 佈局ADC與多特異抗體研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2642250194","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642250194?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 15:07","pubTimestamp":1781248026,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，君实生物涨超5%，截至发稿，涨4.67%，报17.26港元，成交额6560.03万港元。消息面上，近日，君实生物发布公告，公司拟与苏州众合、君实工程、苏州君盟、合资公司上海致域生物医药有限公司及姚盛博士订立合资协议，据此，转让方有条件同意向合资公司授予许可知识产权的一项许可，用于许可产品的研究、开发、制造、使用及商业化；向合资公司转让有形资产；及向合资公司转让IP权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01877","BK4585","BK4080","399441","ADC","BK1515","BK4588","VXUS","BK4231","BK1583","BK1161","XBI","BK4581","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642258981","title":"【灣區早參】港珠澳大橋香港口岸本月25日將啓用「無感通關」；深圳上榜畢業旅行十大熱門城市","url":"https://stock-news.laohu8.com/highlight/detail?id=2642258981","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642258981?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 08:26","pubTimestamp":1781223960,"startTime":"0","endTime":"0","summary":"药明康德公布，已于美国时间本月11日在美国哥伦比亚特区联邦地区法院，对美国国防部提起诉讼。诉讼要求法院判定国防部的决定无效、作废，且不具法律效力。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983601","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","BK1502","BK1224","02490","BK1583","02121","BK1109","BK1141","LU0348767384.USD","BK1237","LU1046422090.SGD","BK6092","BK1601","IE00BYTNYN87.SGD","LU2125910500.SGD","LU2242644610.SGD","BK1613","LU0052750758.USD","BK1602","SG9999011746.SGD","BK1576","01929","LU0708995583.HKD","LU2045819591.USD","BK4231","LU0348766576.USD","BK6511","IE00B12V2V27.USD","IE00BYQNZ168.SGD","01236","09985","BK4080","HK0000288784.HKD","5RE.SI","HK0000288743.USD","BK1103","BK1179","ADC","BK1545","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642237365","title":"基石藥業-B(02616)：CS5007(EGFR/HER3雙特異性ADC)全球多中心I期臨床試驗啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2642237365","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642237365?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 06:10","pubTimestamp":1781215804,"startTime":"0","endTime":"0","summary":"智通财经APP讯，基石药业-B 发布公告，本公司管线2.0核心候选药物CS5007的全球多中心I期临床试验，已正式获得澳大利亚人类研究伦理委员会的许可。这不仅标志着CS5007的全球临床开发全面启动，更意味着本公司管线2.0战略正加速兑现，后续重磅力量已进入临床快车道，有望为中长期增长持续注入信心。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453441.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","BK1161","BK1574","BK4080","02616","ADC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":107,"code":"91000000","status":"200"}]}}